Soleno Therapeutics (SLNO) Cash & Equivalents (QoQ) (2014 - 2026)
Soleno Therapeutics (SLNO) Cash & Equivalents (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.71% |
| Dec 31, 2025 | -71.58% |
| Sep 30, 2025 | 222.48% |
| Jun 30, 2025 | -5.94% |
| Mar 31, 2025 | -7.50% |
| Dec 31, 2024 | 81.62% |
| Sep 30, 2024 | -15.06% |
| Jun 30, 2024 | 33.18% |
| Mar 31, 2024 | -74.78% |
| Dec 31, 2023 | 223.82% |
| Sep 30, 2023 | 170.10% |
| Jun 30, 2023 | 145.57% |
| Mar 31, 2023 | -45.90% |
| Dec 31, 2022 | -26.07% |
| Sep 30, 2022 | -18.05% |
| Jun 30, 2022 | -16.82% |
| Mar 31, 2022 | 36.00% |
| Dec 31, 2021 | -24.41% |
| Sep 30, 2021 | -16.11% |
| Jun 30, 2021 | -19.25% |